Resistance to antiplatelet drugs: current status and future research (Q28192298)

Expert Opinion on Pharmacotherapy

Europe PubMed Central

title

Resistance to antiplatelet drugs: current status and future research (English)

0 references

3

Paul A Gurbel

0 references

author name string

Udaya S Tantry

series ordinal

1

0 references

Kevin P Bliden

series ordinal

2

0 references

language of work or name

English

0 references

publication date

October 2005

0 references

published in

0 references

volume

6

0 references

issue

12

0 references

page(s)

2027-45

0 references

cites work

Central role of the P2Y12 receptor in platelet activation

1 reference

https://api.crossref.org/works/10.1517/14656566.6.12.2027

The role of platelets in peripheral arterial disease: therapeutic implications

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14656566.6.12.2027

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14656566.6.12.2027

Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14656566.6.12.2027

Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14656566.6.12.2027

Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14656566.6.12.2027

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14656566.6.12.2027

Aspirin resistance: definition, mechanisms and clinical read-outs

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14656566.6.12.2027

11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14656566.6.12.2027

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14656566.6.12.2027

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14656566.6.12.2027

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14656566.6.12.2027

Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14656566.6.12.2027

Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14656566.6.12.2027

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14656566.6.12.2027

Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14656566.6.12.2027

Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14656566.6.12.2027

Platelet activation in myocardial ischemic syndromes

20 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Signaling events underlying thrombus formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Platelets in atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

The role of platelet receptors and adhesion molecules in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Role of protease-activated and ADP receptor subtypes in thrombin generation on human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADP

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Two waves of platelet secretion induced by thromboxane A2 receptor and a critical role for phosphoinositide 3-kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Nitric oxide and its relationship to thrombotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Nitric oxide insufficiency, platelet activation, and arterial thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Is there a role for oral anticoagulant therapy in patients with peripheral arterial disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Reperfusion treatment of ST-elevation acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Variability in response to aspirin: do we understand the clinical relevance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Biological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Genetic and acquired determinants of individual variability of response to antiplatelet drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Methods and models to evaluate shear-dependent and surface reactivity-dependent antithrombotic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Acetylation of prostaglandin synthase by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

High-dose aspirin inhibits shear-induced platelet reaction involving thrombin generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of eryt

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Aspirin improves endothelial dysfunction in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Aspirin response and failure in diabetic patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Failure of aspirin to prevent atherothrombosis: potential mechanisms and implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Influence of Smoking on Predictors of Vascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Structure and stereochemistry of the active metabolite of clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Identification of the platelet ADP receptor targeted by antithrombotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Platelet CD40 ligand (CD40L)--subcellular localization, regulation of expression, and inhibition by clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Effectiveness of clopidogrel versus aspirin in preventing acute myocardial infarction in patients with symptomatic atherothrombosis (CAPRIE trial)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Individual variations of platelet inhibition after loading doses of clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

The difference between clopidogrel responsiveness and posttreatment platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Failure of clopidogrel to reduce platelet reactivity and activation following standard dosing in elective stenting: implications for thrombotic events and restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

A new method of representing drug-induced platelet inhibition: better description of time course, response variability, non-response, and heightened activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Interpretation of platelet inhibition by clopidogrel and the effect of non-responders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Variability in platelet responsiveness to clopidogrel among 544 individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Theriac found? Nitric oxide-aspirin and the search for the universal cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

Picotamide versus aspirin in diabetic patients with peripheral arterial disease: has David defeated Goliath?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.12.2027

10.1517/14656566.6.12.2027

21 January 2018

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

16197357

1 reference

Consolidated OpenCitations Corpus – April 2017